Randomised controlled trials (RCTs) deliver the most reliable evidence to guide how we treat our patients but they are badly designed, inaccurately reported and misunderstood.
We can do better.
Simon Finfer is an intensive care clinician and researcher in Sydney, a Professorial Fellow at The George Institute for Global Health, Adjunct Professor at the University of New South Wales, Senior Staff Specialist at Royal North Shore Hospital and Director of Intensive Care at the Sydney Adventist Hospital. Simon was a founding member and is a past-Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group, past chair of the Council of the International Sepsis Forum, and current Vice President of the Global Sepsis Alliance.
Simon was appointed an Officer (AO) in the Order of Australia in the Queen’s Birthday Honours List June 2020 for “distinguished service to intensive care medicine, to medical research and education, and to global health institutes”.
Dr. Hallie Prescott is an Assistant Professor in Pulmonary & Critical Care Medicine at the University of Michigan and staff physician at the Ann Arbor Veterans Affairs Hospital. She leads grants on post-sepsis morbidity and hospital performance measurement from the US National Institutes of Health and the US Department of Veteran Affairs.
She is an expert in long-term outcomes and recovery after sepsis. She is a vice-chair of the Surviving Sepsis Campaign guidelines, council member of the International Sepsis Forum, and a former ANZICS Intensive Care Global Rising Star fellow (2015). [@swamiHalliePrescott]
Professor Carol Hodgson PhD FACP PT is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre at Monash University. She has developed and led international Phase II and III trials to test early interventions to improve long-term outcomes and the quality of survival.
She leads grants (> $15M) for international, randomised trials and a binational registry. Her work as a specialist ICU physiotherapist leading clinical research in Australia and New Zealand has led to a paradigm shift in the treatment of ICU patients, especially rehabilitation practices.
She has over 100 publications in this field and experience developing international guidelines for mechanical ventilation, early mobilisation and the management of sepsis. [@chodgsonANZICRC]
The Coda Community
CODA22: Melbourne from 3-6 April 2022, will be an unparalleled healthcare event guaranteed to inspire your practice